Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HCSG
HCSG logo

HCSG Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Healthcare Services Group Inc (HCSG) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
24.170
1 Day change
-0.58%
52 Week Range
24.520
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Healthcare Services Group Inc (HCSG) is not a strong buy at the moment for a beginner investor with a long-term focus. While the stock has shown positive price momentum and bullish technical indicators, the insider selling trend and lack of recent news or significant positive catalysts suggest caution. Additionally, the absence of Intellectia Proprietary Trading Signals further supports a hold recommendation.

Technical Analysis

The stock is currently in a bullish trend with MACD positively expanding (0.239), RSI at 81.737 indicating overbought conditions, and moving averages showing bullish alignment (SMA_5 > SMA_20 > SMA_200). The price is above the pivot level (21.643) and close to R1 (22.711), suggesting limited immediate upside.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
9

Positive Catalysts

  • Analysts have raised price targets recently, with some projecting significant upside (e.g., Benchmark's target of $30). The company has shown strong quarterly results with earnings beats and guidance for high single-digit top-line growth in the second half of 2026.

Neutral/Negative Catalysts

  • Insiders have significantly increased selling activity (964.46% increase in the last month). Hedge funds are neutral, and there is no recent news or event-driven catalysts. The RSI indicates overbought conditions, suggesting a potential pullback.

Financial Performance

No financial data available for analysis due to an error in the provided dataset.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are mixed but leaning positive. UBS and Benchmark maintain Buy ratings with raised price targets, while RBC and BMO are more cautious with Sector Perform and Market Perform ratings, respectively. Baird downgraded its price target but acknowledged strong quarterly results.

Wall Street analysts forecast HCSG stock price to fall
4 Analyst Rating
Wall Street analysts forecast HCSG stock price to fall
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 24.310
sliders
Low
20
Averages
22
High
24
Current: 24.310
sliders
Low
20
Averages
22
High
24
UBS
Buy
maintain
$25 -> $27
AI Analysis
2026-04-23
Reason
UBS
Price Target
$25 -> $27
AI Analysis
2026-04-23
maintain
Buy
Reason
UBS raised the firm's price target on Healthcare Services to $27 from $25 and keeps a Buy rating on the shares.
RBC Capital
Sector Perform
maintain
$22 -> $24
2026-04-23
Reason
RBC Capital
Price Target
$22 -> $24
2026-04-23
maintain
Sector Perform
Reason
RBC Capital raised the firm's price target on Healthcare Services to $24 from $22 and keeps a Sector Perform rating on the shares. The company reported a strong Q2 earnings beat and maintained guidance but the firm is cautious on the second half ramp, seeking further proof points, the analyst tells investors in a research note. RBC adds that the guide for the second half implies high single-digit top-line growth and is dependent on the timing of new client wins.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HCSG
Unlock Now

People Also Watch